All articles
How to Inject Mounjaro® for Weight Loss: Step-by-Step Guide
Reading time:
4 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
How Mochi Supports a Healthy Weight Loss Journey
Navigating weight loss with Mounjaro® can be challenging, but Mochi Health is here to help. Our team of healthcare professionals offers personalized guidance for monitoring your progress and adjusting your treatment plan as needed. With Mochi Health, you can ensure you're on the right track towards achieving your weight loss goals while managing any side effects effectively.
Conclusion
Injecting Mounjaro® correctly is a key component of your weight loss journey. By understanding the best injection sites and following best practices, you can maximize the benefits of this powerful medication. Always consult your healthcare provider to ensure you're injecting Mounjaro® safely and effectively, and consider leveraging the support of Mochi Health for a successful and healthy weight loss experience.
References:
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Willard, F. S., Douros, J. D., Gabe, M. B., Showalter, A. D., Wainscott, D. B., Suter, T. M., Capozzi, M. E., van der Velden, W. J., Stutsman, C., Cardona, G. R., Urva, S., Emmerson, P. J., Holst, J. J., D'Alessio, D. A., Coghlan, M. P., Rosenkilde, M. M., Campbell, J. E., & Sloop, K. W. (2020). Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI insight, 5(17), e140532. https://europepmc.org/article/pmc/pmc7526454
Rodriguez PJ, Goodwin Cartwright BM, Gratzl S, et al. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity. JAMA Intern Med. Published online July 08, 2024. doi:10.1001/jamainternmed.2024.2525 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080
Food and Drug Administrator. (n.d.-b). Mounjaro®TM (tirzepatide) injection, for subcutaneous use. Access Data FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.
Share this post
Weight loss
More articles

















